6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602452R, 424263, 424271, A61K 31545, A61K 3143, C07D49900

Patent

active

044276788

ABSTRACT:
beta-Lactamase inhibitors which are 6-alpha- and 6-beta(aminomethyl)pencillanic acid 1,1-dioxides which are substituted on amino nitrogen with benzyl, hydroxybenzyl, picolyl or phenethyl; pharmaceutically-acceptable salts thereof; conventional esters thereof hydrolyzable in vivo; pharmaceutical compositions thereof with conventional beta-lactam antibiotics; and a method of treating bacterial infections with said pharmaceutical compositions.

REFERENCES:
patent: 4207323 (1980-06-01), Beattie et al.
patent: 4234579 (1979-03-01), Barth
patent: 4237051 (1980-02-01), McCombie
patent: 4287181 (1981-09-01), Kellogg
Sheehan et al., J. Org. Chem., 42, pp. 4045-4048 (1977).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1287150

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.